Загрузка...
Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma
Sorafenib is an oral multiple kinase inhibitor that blocks Raf, vascular endothelial growth factor receptor, and platelet-derived growth factor receptor. It has been approved in the US and Europe for the treatment of advanced hepatocellular carcinoma (HCC). Sorafenib has demonstrated a 44% increase...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3846497/ https://ncbi.nlm.nih.gov/pubmed/24367212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/HMER.S7123 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|